Zinc deficiency in patients with chronic liver disease in Japan

por Ozeki, Itaru, Arakawa, Tomohiro, Suii, Hirokazu, Tatsumi, Ryoji, Yamaguchi, Masakatsu, Nakajima, Tomoaki, Kuwata, Yasuaki, Toyota, Joji
Publicado 2020

Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis

por Tatsumi, Ryoji, Suii, Hirokazu, Yamaguchi, Masakatsu, Arakawa, Tomohiro, Nakajima, Tomoaki, Kuwata, Yasuaki, Toyota, Joji, Hige, Shuhei
Publicado 2020

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin

por Suii, Hirokazu, Ozeki, Itaru, Tatsumi, Ryoji, Yamaguchi, Masakatsu, Kimura, Mutsuumi, Arakawa, Tomohiro, Nakajima, Tomoaki, Kuwata, Yasuaki, Ohmura, Takumi, Hige, Shuhei, Karino, Yoshiyasu, Toyota, Joji
Publicado 2017

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms

por McPhee, Fiona, Suzuki, Yoshiyuki, Toyota, Joji, Karino, Yoshiyasu, Chayama, Kasuaki, Kawakami, Yoshiiku, Yu, Min Lung, Ahn, Sang Hoon, Ishikawa, Hiroki, Bhore, Rafia, Zhou, Nannan, Hernandez, Dennis, Mendez, Patricia, Kumada, Hiromitsu
Publicado 2015

Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

por Kumada, Hiromitsu, Suzuki, Yoshiyuki, Ikeda, Kenji, Toyota, Joji, Karino, Yoshiyasu, Chayama, Kazuaki, Kawakami, Yoshiiku, Ido, Akio, Yamamoto, Kazuhide, Takaguchi, Koichi, Izumi, Namiki, Koike, Kazuhiko, Takehara, Tetsuo, Kawada, Norifumi, Sata, Michio, Miyagoshi, Hidetaka, Eley, Timothy, McPhee, Fiona, Damokosh, Andrew, Ishikawa, Hiroki, Hughes, Eric
Publicado 2014

HLA-DQB1*03 Confers Susceptibility to Chronic Hepatitis C in Japanese: A Genome-Wide Association Study

por Miki, Daiki, Ochi, Hidenori, Takahashi, Atsushi, Hayes, C. Nelson, Urabe, Yuji, Abe, Hiromi, Kawaoka, Tomokazu, Tsuge, Masataka, Hiraga, Nobuhiko, Imamura, Michio, Kawakami, Yoshiiku, Aikata, Hiroshi, Takahashi, Shoichi, Akuta, Norio, Suzuki, Fumitaka, Ikeda, Kenji, Kumada, Hiromitsu, Karino, Yoshiyasu, Toyota, Joji, Tsunoda, Tatsuhiko, Kubo, Michiaki, Kamatani, Naoyuki, Nakamura, Yusuke, Chayama, Kazuaki
Publicado 2013

Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens

por Reddy, K. Rajender, Pol, Stanislas, Thuluvath, Paul J., Kumada, Hiromitsu, Toyota, Joji, Chayama, Kazuaki, Levin, James, Lawitz, Eric J., Gadano, Adrian, Ghesquiere, Wayne, Gerken, Guido, Brunetto, Maurizia R., Peng, Cheng‐Yuan, Silva, Marcelo, Strasser, Simone I., Heo, Jeong, McPhee, Fiona, Liu, Zhaohui, Yang, Rong, Linaberry, Misti, Noviello, Stephanie
Publicado 2017

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

por Foster, Graham R., Chayama, Kazuaki, Chuang, Wan-Long, Fainboim, Hugo, Farkkila, Martti, Gadano, Adrian, Gaeta, Giovanni B., Hézode, Christophe, Inada, Yukiko, Heo, Jeong, Kumada, Hiromitsu, Lu, Sheng-Nan, Marcellin, Patrick, Moreno, Christophe, Roberts, Stuart K., Strasser, Simone I., Thompson, Alexander J., Toyota, Joji, Paik, Seung Woon, Vierling, John M., Zignego, Anna L., Cohen, David, McPhee, Fiona, Wind-Rotolo, Megan, Srinivasan, Subasree, Hruska, Matthew, Myler, Heather, Portsmouth, Simon D.
Publicado 2016